Ade Deane-Pratt

New drug treatment may be a future alternative to gene replacement therapy for choroideremia

Ataluren overrides the genetic glitch in human cells from a patient and in a zebrafish version of the disorder

Find out more

New funds for eye research from Fight for Sight and partner charities

Find out what’s in the autumn 2016 awards

Find out more

Fight for Sight and Sparks partner to fund childhood blindness research

Researchers at the University of Bath are developing a test for a complication of childhood arthritis that affects the eye

Find out more

Retinitis pigmentosa gene discovery may reveal a new route to inherited blindness

RP Genome Project research discovers 6 faults in the REEP6 gene that affect families in the UK and USA

Find out more

Gut microbes can influence the risk of wet AMD

High-fat diet leads to inflammation throughout the body and can prompt unhealthy new blood vessel growth in the eye

Find out more

Retinal activity in autism, ADHD and Duchenne muscular dystrophy

Fight for Sight and Thomas Pocklington Trust form new partnership to fund vision research

Find out more

Tackling the causes of inherited blindness that affect adults and children

Fight for Sight and National Eye Research Centre partner to co-fund two new studies

Find out more

New type of glaucoma treatment in clinical trial

Researchers aim to protect the optic nerve instead of lowering eye pressure

Find out more

Peek founder wins lifetime achievement award

The award is part of the Clearly campaign for better eye care

Find out more

Better options for treating birdshot

New research funding partnership between Fight for Sight and Birdshot Uveitis Society

Find out more

Cell transplant study points to a potential new way to repair the retina

Researchers discover a new type of communication between donor photoreceptors developed from stem cells and host photoreceptors in mice with retinal dystrophy

Find out more

Human breast milk drops help the cornea to heal from wounds

Researchers think it could become an alternative to existing treatments

Find out more

Making history with Professor Robert MacLaren

The Ophthalmologist magazine has a great feature on the world’s first robot-assisted eye surgery

Find out more

Charity funding is paramount to UK research

An AMRC infographic on the impact medical research charities have on the UK research environment.

Find out more

All eyes on the Nobel Prize

The award-winning researcher's work on cell recycling is vital for understanding sight loss

Find out more

NICE approve Eylea to treat sight-threatening condition

Aflibercept can now be used as the first choice for NHS treatment in macular oedema due to branch retinal vein occlusion

Find out more

New and emerging treatments for corneal disorders

NIHR report finds 130 upcoming technologies and procedures

Find out more

Overview – Drs Imre Lengyel and Alan Stewart on AMD

Dr Lengyel and Dr Stewart give a 2-minute summary of their research into a hallmark sign of age-related macular degeneration

Find out more

Shortt reports: the view from Ophthalmology Futures Forum 2016

Fight for Sight researcher Dr Alex Shortt's quick video summaries of the meeting between industry and top clinicians on the future of treatments for the eye and sight loss.

Find out more

Robot surgery restores sight

The PRECEYES system is in use at Oxford’s John Radcliffe Hospital

Find out more

Treating macular degeneration: Fulbright Fight for Sight Research Award 2016

Dr Shyamanga Borooah takes the 5th annual award from the prestigious USA-UK partnership for eye research

Find out more

New funds for Scottish research on age-related eye conditions

Fight for Sight teams up with the Scottish government’s Chief Science Office

Find out more

High eye pressure in glaucoma may be due to an overactive control gene in the drainage system

A common variation in the microRNA gene miR-182 is linked to primary open angle glaucoma

Find out more

Alcohol abuse drug can be repurposed to treat a blinding disorder

Disulfiram prevents scars forming in a mouse model of scarring conjunctivitis and returns human scarring cells from people with the condition back to normal

Find out more

Uveitis drug gets approval in Europe

Adalimumab is the first ‘biologic’ drug licensed to treat some types of non-infectious inflammation in the middle part of the eye

Find out more

Stem cell injection could reduce the risk of sight loss from glaucoma

Researchers in the USA show that the eye’s drainage system can be repaired

Find out more

An alternative to corneal transplant for a common corneal disorder

Small USA study shows minor surgery improves vision for 3 in 4 treatments

Find out more

Nerve cell connections regrow and partly restore sight in mice with optic crush injury

A major step forward for optic nerve regeneration research

Find out more

Google DeepMind partners with Moorfields to help diagnose eye conditions sooner

One million digital eye scans will be analysed using artificial intelligence

Find out more

Central to vision

Spotlight on research into conditions that affect the macula during Macula Week 2016.

Find out more

Tackling the cause of sight loss in Usher syndrome

Spotlight on retinitis pigmentosa during Deafblind Awareness Week 2016

Find out more

Patients think Peek could transform eye health

Healthcare workers and eye service decision-makers also give positive reviews for the smartphone suite

Find out more

Inflammation and scarring form a positive feedback loop in trachoma

Results from two Fight for PhD students take us closer to developing treatment to prevent blindness from a widespread tropical condition

Find out more

Overview - Dr Tiarnan Keenan on AMD

Dr Keenan gives a 1-minute summary of his research on a genetic fault that increases the risk of getting age-related macular degeneration.

Find out more

Fight for Sight PhD students tackle the silent thief of sight

Developing new tests for detecting and monitoring glaucoma and understanding the condition in it rare and most common forms

Find out more

New inserts will not reverse the symptoms of glaucoma

But the good news is that they may be better at preventing future sight loss than existing glaucoma treatments.

Find out more

Help us review up-and-coming treatments for corneal disorders

We’re looking for patients, relatives and carers of people with corneal conditions to join a 2-hour focus group in London on 27 May.

Find out more

Choroideremia gene therapy gives long-term benefit to vision

Encouraging results from a 3.5-year follow up to the Phase I clinical trial

Find out more

Preventing secondary cataract

A new focus for AMD drug target could reduce the need for millions of follow-up eye operations

Find out more

Professor Sir Peng Tee Khaw recognised for impact in ophthalmology

World-renowned glaucoma surgeon voted member of The 2016 Power List

Find out more

Rescuing human light-sensors in a common form of Leber congenital amaurosis

Fight for Sight-funded scientists successfully test new potential treatment for severe inherited childhood sight loss

Find out more

Help us plan a study to find out about UK eye health

Join the United Kingdom Eye Survey as a lay member of the Board

Find out more

New sight test detects early AMD

Fight for Sight researchers design an eye chart that could lead to earlier diagnosis for millions of people

Find out more

Poppers and eye health

A round-up of what we know about a popular ‘drug’ that may be linked to sight loss

Find out more

Eight new PhD studentships for 2016-19

Fight for Sight has awarded a new round of grants for eye research.

Find out more

Fats, sugar and energy: a new way to think of treating wet AMD?

Research points to a potentially safer way to stop sight-threatening blood vessels growing in the eye

Find out more

Measuring eye pressure in glaucoma research using iPerfusion

#WorldGlaucomaWeek: Fight for Sight researchers develop a new tool that could make it easier to develop new treatments

Find out more

Stem cells regrow the lens and repair the front of the eye

A new cataract surgery technique could mean the end of artificial lenses and researchers take a first step towards growing new eyes

Find out more

Fighting the silent thief of sight

A World Glaucoma Week round-up of recent advances in glaucoma research from Fight for Sight scientists

Find out more

High-precision robotic system targets eye surgery

NightstaRx and the University of Oxford team-up with Dutch technology company

Find out more

Understanding the mechanics of a rare blinding disorder passed from parents to their children

Scientists have identified a key cause of damage to the cornea in Meesmann epithelial corneal dystrophy.

Find out more

Leading infectious cause of blindness linked to sexually transmitted infection

Chlamydia can exchange genes between sites of infection

Find out more

Scientists discover genetic changes linked to a major risk factor for blinding trachoma

Aiming to understand why the effects of brief infections are so long-lasting in the world’s leading infectious cause of blindness

Find out more

Variations in the gene SLC19A3 protect against diabetic retinopathy

Differences in the way the body uses vitamin B1 affect the risk of complications from diabetes

Find out more

No miracle cure for dry AMD

A look behind the headlines at reports that cholesterol-lowering statins improve vision

Find out more

Gene editing improves vision in rat retinitis pigmentosa

A 'revolutionary' new tool that’s also showing promise in X-linked RP and corneal dystrophy research.

Find out more

Breakthrough discovery in the genetics of corneal dystrophies

A step towards treatment that could end the need for transplant surgery

Find out more

Clinical trials for age-related macular degeneration

Researchers are taking note of the Sight Loss and Vision Priority Setting Partnership

Find out more

Scientists pinpoint 3 new genes linked to the risk of primary open-angle glaucoma

Results part-funded by Fight for Sight suggest new targets for screening, prevention and treatment.

Find out more

Rare and common genetic faults that affect the risk of age-related macular degeneration.

New genes discovered in a study that will improve the way future research is done.

Find out more

A look back at eye research in 2015

12 months and some really exciting steps forward

Find out more

Scientists identify variations in the AIPL1 gene that cause Leber congenital amaurosis

The results are a vital step towards gene therapy for a cause of severe sight loss in young children. We co-funded the research together with RP Fighting Blindness.

Find out more

Exercise could help treat amblyopia

Results in adults with normal vision point to a possible future treatment for adults with 'lazy eye'

Find out more

Fight for Sight’s research round-up 2015

Spotlight on inherited eye disorders, AMD, glaucoma and corneal blindness

Find out more

New funds for eye research in our autumn 2015 grants round

Fight for Sight’s Small Grant Award Schemes for 2015 have funded 21 new research projects at a cost of £0.3 million.

Find out more

Visual stress could be a symptom of ME

Problems looking at patterns might help diagnose the condition also known as chronic fatigue syndrome (CFS)

Find out more

Low-dose eye drops slow short-sightedness by half in growing children

The treatment could become an important part of preventing sigh loss worldwide

Find out more

Medical Research Council announces funds for AMD clinical trials

A new approach that might help the people who don't respond to standard treatment.

Find out more

Parkinson’s drug could treat macular degeneration

A study of millions of health records shows levodopa delays or prevents a major cause of sight loss.

Find out more

$35 million more to gene therapy for inherited retinal conditions

NightstaRx secures investment from venture capital firm New Enterprise Associates

Find out more

Something good to say about cholesterol

How close are we to developing a non-surgical treatment for cataract?

Find out more

Sterol eye drops make cataracts less cloudy

Promising research in animals and human tissue on developing non-surgical treatment.

Find out more

Gene therapy halts sight loss in dogs with late-stage retinitis pigmentosa

Results from the study suggest treatment can preserve useful vision for at least 2 years.

Find out more

Recycling in the eye is key to seeing in colour and bright light

A discovery that might one day lead to preventing sight loss from age-related macular degeneration.

Find out more

Gene therapy researcher wins MRC/Fight for Sight Clinical Training Fellowship award

Dr Harry Orlans will work at the University of Oxford to develop a treatment for dominant retinitis pigmentosa.

Find out more

Scientists test new gene therapy in Leber hereditary optic neuropathy

The treatment restored vision to mice with the most common genetic fault to cause the condition in humans.

Find out more

High-tech face furniture

A look at some potential ways to improve vision in AMD and after eye cancer and at new technology to correct refractive error.

Find out more

Would you and your child like to take part in an exciting research study?

Researchers at Great Ormond Street are studying ‘cerebral visual impairment’.

Find out more

VISION 2020 UK hosts seminar for funders of eye research

The first ever Funders of Eye Research Summit (FundERS 2015) was created in association with Fight for Sight.

Find out more

Stem cell surgery aims to give sight back to people with AMD

A 60-year-old woman has become the world’s first person to have an experimental stem cell treatment for age-related macular degeneration.

Find out more

Treating keratoconus in children and young people

Find out more

Research to edit the human genome should go ahead, say leading UK science bodies

A joint statement calls for a broad and inclusive discussion about the future implications.

Find out more

Hidden lesions predict the risk of sight loss from diabetic retinopathy

New 'wide-field' imaging can see more of the retina and reveal who is most at risk.

Find out more

2015 Fulbright Fight for Sight Research Award announced

Focus on: diabetic retinopathy

Find out more

Cataract treatment with eye drops instead of surgery could be coming soon

Promising pre-clinical research shows that lanosterol can turn cloudy lenses clear

Find out more

What’s on the horizon to treat inherited retinal diseases?

A review of new and emerging technologies highlights some really important concerns that come directly from patients.

Find out more

Gene therapy gives long-term protection to photoreceptor cells in a mouse model of retinitis pigmentosa

Fight for Sight results published in Molecular Therapy show that the cells could drive visually-guided behaviour, even in late stage disease.

Find out more

Clean-up cells munch through photoreceptors in retinitis pigmentosa

Microglia could make a new target for treatment to slow sight loss.

Find out more

Canadian gene therapy trial to treat choroideremia

Biopharmaceutical company Nightstar announces new study at the University of Alberta.

Find out more

Researchers identify genetic fault that can cause a keyhole shape in the eye

UK and Italian researchers have discovered the genetic cause of a rare form of blindness, in a project co-funded by Fight for Sight.

Find out more

Fight for Sight is working to prevent sight loss due to diabetes

A look at our diabetic retinopathy research for Diabetes Week.

Find out more

Nine new research projects funded in our spring 2015 grants round

The projects will take place at top UK institutions in Belfast, London, St Andrews, Edinburgh, Cardiff and Durham.

Find out more

Faulty ‘housekeeping’ gene causes rare form of complete colour blindness

International research team discovers unexpected role for ATF6 in vision.

Find out more

Peek eye test app works as well as visual acuity charts

Study shows the Peek Acuity app is as fast and accurate as using standard eye charts.

Find out more

New form of inherited blindness discovered

RP Genome Project research reveals that the gene DRAM2 is essential for vision.

Find out more

Short-sightedness on the rise in the young

Young people of European ancestry are more likely to be short-sighted than older generations.

Find out more

Fight for Sight cataract researcher wins international award

USA’s National Foundation for Eye Research recognises Dr Michael Wormstone's significant scientific work on the lens

Find out more

A temporary benefit to night vision

Final results from the first clinical trial of gene therapy for Leber congenital amaurosis.

Find out more

Deadly ‘diet drug’ can also damage your eyes

Dinitrophenol (DNP) linked to serious side-effects including fast-forming cataracts and glaucoma.

Find out more

Stem cell injection has potential to halt sight loss in early AMD

Results from a pre-clinical study show that a single injection lead to benefits lasting '16 human years'.

Find out more

New gene for Leber congenital amaurosis

Faults in PNPLA6 lead to the death of light-sensitive cells in the eye.

Find out more

Different barriers to cell transplant success between the inherited eye conditions

The process of scarring in the retina after photoreceptor loss varies on the genetic fault behind the condition.

Find out more

Give wet AMD drug early to keep sight for longer

New study finds it's better to start treatment when sight test scores are under 6/12

Find out more

South-east England ahead on genetic tests for inherited eye conditions

The results are part of Fight for Sight's REGARD programme to build an optimal, patient-led model of care services.

Find out more

What’s the best way to spot wet AMD early?

A study at hospitals across the UK to compare currently available NHS tests to the 'gold standard' diagnostic test.

Find out more

Gene therapy for choroideremia gets ‘orphan drug’ status

UK and USA regulators approve the incentive to develop treatments for rare conditions

Find out more

Seven new PhD studentship awards for 2015

Fight for Sight has awarded seven new PhD studentships in eye research for 2015.

Find out more

A new source of stem cells for repairing the cornea

Teeth may be a good source of cells to repair the eye and restore sight.

Find out more

New gene linked to glaucoma

Find out more

New choroideremia gene therapy clinical trial

Researchers at the University of Pennsylvania are to begin the first US clinical trial of gene therapy for choroideremia

Find out more

An extra £5 million for gene therapy start up

Syncona LLP increases its investment in independent pharmaceutical Nightstar to £17 million

Find out more

Eye health could help diagnose people with chronic fatigue syndrome

We partner with Thomas Pocklington Trust to co-fund research into a little-known aspect of this disabling, long-term condition.

Find out more

Calcium in the back of the eye may be a trigger for AMD

A mineral found in teeth and bones is identified in the macula for the first time.

Find out more

Can 3D facial imaging help manage a disfiguring cause of sight loss?

Fight for Sight and British Thyroid Foundation partner to co-fund new research

Find out more

UK clinical trials of a new potential drug treatment for uveitis

Find out more

Smartphone eye examination app Peek Retina goes for crowdfunding

Indiegogo appeal to raise extra funds for Peek to be manufactured and delivered globally

Find out more

‘No water’ campaign warns of a sight-threatening infection

Contact lens manufacturer adds 'No water’ campaign message to their packaging to raise awareness of Acanthamoeba keratitis – a serious, sight-threatening eye infection.

Find out more

Eye disorders identified by how we watch TV

Fight for Sight researchers publish proof-of-principle study that could lead to new tests for glaucoma and other sight loss conditions.

Find out more

Next-generation genetic test points the way to personalised care for children born with cataracts

Find out more